Bacterial Drug Delivery Systems for Cancer Therapy: “Why” and “How”
Pharmaceutics · 27.08.2023 · 15 (9) · 2214
DOI: 10.3390/pharmaceutics15092214 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 27.08.2023. Verfasst von Xiangcheng Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Xiangya School of Pharmaceutical Science, Central South University, Changsha 410006, China. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer is one of the major diseases that endanger human health. However, the use of anticancer drugs is accompanied by a series of side effects. Suitable drug delivery systems can reduce the toxic side effects of drugs and enhance the bioavailability of drugs, among which targeted drug delivery systems are the main development direction of anticancer drug delivery systems. Bacteria is a novel drug delivery system that has shown great potential in cancer therapy because of its tumor-targeting, oncolytic, and immunomodulatory properties. In this review, we systematically describe the reasons why bacteria are suitable carriers of anticancer drugs and the mechanisms by which these advantages arise. Secondly, we outline strategies on how to load drugs onto bacterial carriers. These drug-loading strategies include surface modification and internal modification of bacteria. We focus on the drug-loading strategy because appropriate strategies play a key role in ensuring the stability of the delivery system and improving drug efficacy. Lastly, we also describe the current state of bacterial clinical trials and discuss current challenges. This review summarizes the advantages and various drug-loading strategies of bacteria for cancer therapy and will contribute to the development of bacterial drug delivery systems.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Xiangya School of Pharmaceutical Science, Central South University, Changsha 410006, China.
- Changsha Jingyi Pharmaceutical Technology Co., Ltd., Changsha 410006, China.
ORCID-Profile: Wenhu Zhou
Zitieren
APA
Zhao, X., Xie, N., Zhang, H., Zhou, W., & Ding, J. (2023). Bacterial Drug Delivery Systems for Cancer Therapy: “Why” and “How”. Pharmaceutics, 15(9), 2214. https://doi.org/10.3390/pharmaceutics15092214
Vancouver
Zhao X, Xie N, Zhang H, Zhou W, Ding J. Bacterial Drug Delivery Systems for Cancer Therapy: “Why” and “How”. Pharmaceutics. 2023;15(9):2214. doi:10.3390/pharmaceutics15092214
BibTeX
@article{Zhao2023,
author = {Zhao, Xiangcheng and Xie, Nuli and Zhang, Hailong and Zhou, Wenhu and Ding, Jinsong},
title = {Bacterial Drug Delivery Systems for Cancer Therapy: “Why” and “How”},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {9},
pages = {2214},
doi = {10.3390/pharmaceutics15092214}
}
EUVIMED